Groups | Type of cancer | Parameter | μg Pt/g Cr | μg Se/g Cr | ng As/g Cr |
---|---|---|---|---|---|
Cisplatin (Group 1) | Lung | X | 1.05 | 143.0 | 5.57 |
Med | 1.06 | 49.0 | 2.08 | ||
DS | 0.625 | 263.0 | 8.94 | ||
n | 32 | 24 | 21 | ||
Min | 0.136 | 7.0 | 0.360 | ||
Max | 2.52 | 1028.0 | 31.1 | ||
Cisplatin (Group 2) | Other | X | 1.39 | 83.9 | 7.96 |
Med | 0.969 | 40.7 | 2.55 | ||
DS | 1.59 | 186.0 | 17.1 | ||
n | 47 | 36 | 31 | ||
Min | 0.110 | 11.3 | 0.280 | ||
Max | 7.26 | 1136.0 | 91.2 | ||
Carboplatin (Group 3) | Other | X | 13.3 | 156.0 | 10.1 |
Med | a | a | a | ||
DS | 9.76 | 182.0 | 18.5 | ||
n | 11 | 9 | 6 | ||
Min | 0.780 | 25.5 | 0.40 | ||
Max | 32.5 | 484.0 | 47.7 | ||
Control 1 (b) (Group 4) | Other | X | 51.6 | ||
Med | a | ||||
DS | 33.7 | ||||
n | 7 | ||||
Min | 5.30 | ||||
Max | 92.3 | ||||
Control 2 (c) (Group 5) | Lung and other | X | 61.9 | ||
Med | a | ||||
DS | 20.4 | ||||
n | 9 | ||||
Min | 28.1 | ||||
Max | 90.4 |